HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S M Firth Selected Research

Transforming Growth Factor-beta Type II Receptor

12/2000Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S M Firth Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
05/2013 - 08/2000
2Neoplasms (Cancer)
05/2013 - 05/2004
1Hypoxia (Hypoxemia)
05/2013
1Starvation
05/2013

Drug/Important Bio-Agent (IBA)

4Insulin-Like Growth Factor Binding Protein 3IBA
05/2013 - 08/2000
4Insulin-Like PeptidesIBA
05/2013 - 12/2000
3Proteins (Proteins, Gene)FDA Link
05/2013 - 12/2000
1Endoplasmic Reticulum Chaperone BiPIBA
05/2013
1Glucose (Dextrose)FDA LinkGeneric
05/2013
1Growth InhibitorsIBA
05/2013
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2004
1Apoptosis Regulatory ProteinsIBA
12/2000
1Transforming Growth Factor-beta Type II ReceptorIBA
12/2000
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1Complementary DNA (cDNA)IBA
12/2000
1Insulin-Like Growth Factor Binding ProteinsIBA
12/2000
1EnzymesIBA
12/2000
1insulin-like growth factor binding protein-3 proteaseIBA
12/2000
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2000
1DNA (Deoxyribonucleic Acid)IBA
12/2000
1Peptides (Polypeptides)IBA
12/2000
1Insulin-Like Growth Factor Binding Protein 5IBA
08/2000